ETIOLOGICAL PERIODONTAL TREATMENT WITH AND WITHOUT LOW LEVEL LASER THERAPY ON IL-1β LEVEL IN GINGIVAL CREVICULAR FLUID: AN IN VIVO MULTICENTRIC PILOT STUDY

Cytokine proteins may have important roles during different human physiological and pathological processes. In the oral cavity, the bone loss and periodontal tissue pathology was related to inflammatory process activation. The aim of the present study was to assess the effects of etiological periodontal therapy with and without the use of Low Level Laser Therapy (LLLT) on clinical periodontal parameters and interleukin(IL)-1 beta level in gingival crevicular fluid (GCF) from chronic periodontitis (CP) patients. Thirty non-smoker CP patients were selected from the Foggia University Dental Clinic and other 2 private dental clinics. All patients were divided into two homogeneous randomized groups: 15 patients were treated with only scaling and root planing (group 1) and 15 patients with scaling and root planing etiological treatment and LLLT (group 2). In all sites, at baseline before treatment, the periodontal pocket depth (PPD) and bleeding on probing (BOP) were measured. In the PPD sites, the GCF samples were collected from 30 deep (>= 5 mm) and shallow (<= 3 mm) sites and IL-1 beta were evaluated at baseline, after 10 days and 1 month. In all the samples at baseline, the IL-1 beta concentration in GCF and BOP rate were significantly higher at deep PPD sites than at the shallow ones. After 10 days in all samples no PPD improvement was observed in the BOP rate but the IL-1 beta level was statistically significantly improved (p<0.005) in group 2 compared to group 1. At 10 days and I month, in all deep PPD sites, PPD and BOP improvements were observed. At same time, IL-1 beta levels were lower and statistically significantly (p<0.005) improved in group 2 compared to group 1. The results confirmed that the periodontal etiology treatment of deep PPD sites with or with-out associated LLLT promotes periodontal health. Etiological treatment associated with LLLT, improves BOP and inflammation in periodontal disease. Moreover, the IL-1 beta concentration changes in GCF suggest these cytokines as a predictable marker of gingival inflammation in chronic periodontitis patients.